Disability News and Research

RSS

CAR-T cell therapy shows promise for treating rheumatoid arthritis

Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.

3 Jun 2026

New PET imaging approach quantifies synaptic pathology in multiple sclerosis

A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the brain's functional wiring in patients with multiple sclerosis.

2 Jun 2026

Tailored meal programs reduce hospitalizations for chronic disease patients

At least a dozen U.S. states are rolling out medically tailored meals in pilot projects through Medicaid, the federal–state health insurance program serving 71 million Americans who qualify based on income or disability status.

2 Jun 2026

Shopping data reveals hidden period pain disparities in England

The study highlights how shopping behavior reflects menstrual pain prevalence, revealing inequalities in health management across income levels.

2 Jun 2026

Researchers develop real time sensor system for early detection of ICU brain infections

A research team led by the University of Waterloo has created a new monitoring system to save lives and significantly reduce health-care costs in brain-injury cases through the early detection of infections in intensive care units.

2 Jun 2026

AI is mapping health stigma faster than it is fixing it

This scoping review of 70 studies found that AI is used mainly to detect and measure health-related stigma, rather than to reduce it. Evidence that AI can reduce stigma remains early, limited, and concentrated in mental health conversational-agent studies.

1 Jun 2026

Higher-dose ocrelizumab depletes more B cells but does not slow MS progression

Higher-dose ocrelizumab produced greater peripheral B-cell depletion than the approved 600 mg regimen in two phase 3b trials of relapsing and primary progressive multiple sclerosis. However, the higher doses did not significantly delay disability progression, supporting the 600 mg dose as the current standard regimen with a favorable benefit-risk profile.

31 May 2026

New protocol screens clinical research participants for prior radiation exposure

A new study highlights a critical gap: most clinical research studies that use imaging techniques such as amyloid positron emission tomography (PET) scans do not account for the radiation participants have already received from prior medical procedures.

29 May 2026

Sociological shifts change expectations and behaviors of modern patients

Whereas patients in the past were expected to be patient, grateful, passive and docile - many of today's patients are assertive, demanding, impatient and insistent. So, what has happened?

29 May 2026

Ocrelizumab slows disability progression in advanced progressive multiple sclerosis

A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a medication already prescribed to some patients with MS – significantly slows disability progression in people with primary progressive multiple sclerosis (PPMS), including older patients and those with more advanced disease who are wheelchair users.

28 May 2026

Major trial compares surgical approaches for treating Chiari malformation and syringomyelia

A nationwide study has shed new light on how to most effectively and safely treat Chiari malformation and syringomyelia, rare neurological diseases that impact both children and young adults.

27 May 2026

Adults with developmental disabilities or cerebral palsy face earlier fall injury risks

Falls are a common cause of injury, especially for adults over age 65. But adults with intellectual and/or developmental disabilities or cerebral palsy may also be at higher risk.

26 May 2026

Food insecurity links to poorer mental and physical health in Tasmania

Food insecurity among adults in Tasmania was strongly associated with lower diet satisfaction and poorer self-rated mental and physical health, with diet dissatisfaction showing the strongest link. The findings suggest that food insecurity limits not only nutrition, but also food choice, agency, wellbeing, and equitable access to acceptable, affordable, and culturally appropriate diets.

24 May 2026

Mental disorders surpass other conditions as leading global cause of disability

Nearly 1.2 billion people worldwide are living with a mental disorder, nearly double the number recorded in 1990.

22 May 2026

Structured approach to a healthy lifestyle may help slow important aspects of aging

Researchers at Wake Forest University School of Medicine found evidence of slowed aging from lifestyle behaviors like healthy eating and exercise as part of a major clinical trial.

21 May 2026

Phase two clinical trial demonstrates dramatic mobility gains in children with severe fibrous dysplasia

Fibrous dysplasia is a rare skeletal disorder in which normal bone is gradually replaced by weak fibro-osseous tissue, leading to fractures, pain, deformities, and severe mobility impairment. In many patients, diseased bone tissue produces excessive amounts of fibroblast growth factor-23 (FGF23), a hormone that causes phosphate loss through the kidneys.

21 May 2026

Rural siblings of neurodivergent children face poorer mental wellbeing

New Curtin University-led research has found siblings of people with neurodevelopmental conditions in regional and remote Australia are struggling with poorer wellbeing and are more likely to feel overlooked.

21 May 2026

UCLA researchers identify potential drug target for treating Fragile X syndrome

UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly 1 in 2,000 boys.

18 May 2026

Tuberculosis drives trillion dollar economic crisis, research shows

The impacts of tuberculosis (TB) are usually discussed in terms of public health and human suffering. Now, new research presented at the 2026 ATS International Conference shows that TB is also driving a massive global economic crisis.

18 May 2026

Research identifies significant spike in neurological disorders during the covid-19 pandemic

In 2021, neurological diseases affected 3.40 billion individuals worldwide, corresponding to 43.1 % of the global population. In China, rapid demographic shifts and lifestyle changes have contributed to a continued rise in the burden of stroke, dementia, and Parkinson's disease-a trend expected to persist.

15 May 2026

Disability News and Research

CAR-T cell therapy shows promise for treating rheumatoid arthritis

New PET imaging approach quantifies synaptic pathology in multiple sclerosis

Tailored meal programs reduce hospitalizations for chronic disease patients

Shopping data reveals hidden period pain disparities in England

Researchers develop real time sensor system for early detection of ICU brain infections

AI is mapping health stigma faster than it is fixing it

Higher-dose ocrelizumab depletes more B cells but does not slow MS progression

New protocol screens clinical research participants for prior radiation exposure

Sociological shifts change expectations and behaviors of modern patients

Ocrelizumab slows disability progression in advanced progressive multiple sclerosis

Major trial compares surgical approaches for treating Chiari malformation and syringomyelia

Adults with developmental disabilities or cerebral palsy face earlier fall injury risks

Food insecurity links to poorer mental and physical health in Tasmania

Mental disorders surpass other conditions as leading global cause of disability

Structured approach to a healthy lifestyle may help slow important aspects of aging

Phase two clinical trial demonstrates dramatic mobility gains in children with severe fibrous dysplasia

Rural siblings of neurodivergent children face poorer mental wellbeing

UCLA researchers identify potential drug target for treating Fragile X syndrome

Tuberculosis drives trillion dollar economic crisis, research shows

Research identifies significant spike in neurological disorders during the covid-19 pandemic

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News